AstraZeneca’s Danicopan Among Four Orphans Up For EU Approval Decision

 
• By Eliza Slawther

The European Medicines Agency is due to decide whether to back pan-EU marketing authorization for 11 new products, including four orphan drugs.

Thumb up and thumb down
It's decision time for 11 products at the EMA • Source: Shutterstock

More from Europe

More from Geography